CMML: GM-CSF inhibitor lenzilumab shows early promiseJune 20, 2023AMLMyelodysplastic SyndromeMixed Topics
ASCO honors Hagop Kantarjian, MD, for leukemia researchMay 16, 2023AMLBusiness of MedicineMixed TopicsMyelodysplastic SyndromeHematologic Malignancies
VEXAS syndrome: More common, variable, and severe than expectedJanuary 24, 2023Rare DiseasesMyelodysplastic Syndrome
‘Extremely exciting’ study results guide MM treatment optionsJune 6, 2022Multiple MyelomaAMLMyelodysplastic SyndromeMixed TopicsHematologic MalignanciesOncology
Myeloid patients respond robustly to Moderna COVID vaccineDecember 12, 2021COVID-19 UpdatesAMLMyelodysplastic Syndrome
For leukemias, COVID-19 death risks tied to poor prognoses, ICU deferralsDecember 11, 2021COVID-19 UpdatesMyelodysplastic SyndromeAML
Genetic mutation burden can predict prognosis for myelodysplastic syndromeDecember 15, 2020Myelodysplastic Syndrome
Novel gene fusions surface more often in acute myeloid leukemia vs. myelodysplastic syndromeDecember 15, 2020Myelodysplastic Syndrome
Azacitidine shows safety but lacks effectiveness for relapse reduction in myelodysplastic syndrome and acute myeloid leukemiaDecember 15, 2020Myelodysplastic Syndrome
Imetelstat curbs need for blood transfusions in myelodysplastic syndrome December 15, 2020Myelodysplastic Syndrome
Food supplements improve mitochondrial respiration in myelodysplastic syndromeDecember 15, 2020Myelodysplastic Syndrome
Monthly azacitidine injections reduce relapse in acute myeloid leukemia and myelodysplastic syndromeDecember 15, 2020Myelodysplastic Syndrome
